François Raffi

On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection

Jean‐Michel Molina, Catherine Capitant, Bruno Spire et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Public Health, Pharmacotherapy, Preventive Medicine +17

Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study

Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham et al. · The Lancet · 2004 · 683 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study

Caroline Charlier, Élodie Perrodeau, Alexandre Leclercq et al. · The Lancet Infectious Diseases · 2017 · 577 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +12

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink et al. · The Lancet · 2013 · 546 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +12

Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial

Jean‐Michel Molina, Isabelle Charreau, Christian Chidiac et al. · The Lancet Infectious Diseases · 2017 · 445 citations · Full text

Medicine, Infectious Diseases, Preventive Medicine +12